Endo names ex-Nora Therapeutics CEO as COO
Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer.
The company said McHugh will assume her new role on Monday. Endo has not had a chief operating officer since Sept. 1, 2009.
Before working at Nora, a biotech startup backed by venture capital money, McHugh spent 12 years at Johnson & Johnson.
Endo Pharmaceuticals is a specialty pharmaceutical company involved with drugs used to treat and manage pain, prostate cancer and the early onset of puberty in children.
Its shares rose 22 cents to $23.67 in morning trading Friday.
(This version CORRECTS SUBS 2nd graf to REMOVE INcorrect information on another official.)